We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+19.6%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$269M
AUM Growth
+$71.2M
Cap. Flow
+$40.1M
Cap. Flow %
14.87%
Top 10 Hldgs %
31.44%
Holding
57
New
13
Increased
18
Reduced
17
Closed
7

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$7.45M
2
BIIB icon
Biogen
BIIB
+$5.55M
3
AMGN icon
Amgen
AMGN
+$5.51M
4
CNC icon
Centene
CNC
+$5.15M
5
ZBH icon
Zimmer Biomet
ZBH
+$4.98M

Top Sells

Rank Stock Value
1
WCG
Wellcare Health Plans, Inc.
WCG
+$5.18M
2
BDX icon
Becton Dickinson
BDX
+$5.06M
3
CELG
Celgene Corp
CELG
+$4.96M
4
ALC icon
Alcon
ALC
+$3.15M
5
DGX icon
Quest Diagnostics
DGX
+$2.35M

Sector Composition

Rank Sector Weight
1 Healthcare 98.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQV icon
26
IQVIA
IQV
$40.1B
$5.41M 2.01%
35,000
+5,000
+17% +$730K
ZTS icon
27
Zoetis
ZTS
$31.1B
$5.29M 1.97%
40,000
+10,000
+33% +$1.24M
SYK icon
28
Stryker
SYK
$134B
$5.25M 1.95%
25,000
– –
ZBH icon
29
Zimmer Biomet
ZBH
$18.5B
$5.24M 1.94%
+36,050
New +$4.98M
ABT icon
30
Abbott
ABT
$190B
$5.21M 1.93%
60,000
-20,000
-25% -$1.68M
JNJ icon
31
Johnson & Johnson
JNJ
$626B
$5.11M 1.9%
+35,000
New +$4.75M
MDT icon
32
Medtronic
MDT
$116B
$5.11M 1.9%
45,000
+5,000
+13% +$549K
ABBV icon
33
AbbVie
ABBV
$442B
$4.43M 1.64%
+50,000
New +$4.15M
LH icon
34
Labcorp
LH
$26.1B
$4.23M 1.57%
29,100
-5,820
-17% -$840K
ALGN icon
35
Align Technology
ALGN
$12.3B
$4.19M 1.55%
+15,000
New +$3.74M
SNN icon
36
Smith & Nephew
SNN
$12.6B
$3.6M 1.34%
+75,000
New +$3.38M
EW icon
37
Edwards Lifesciences
EW
$54B
$3.5M 1.3%
45,000
-30,000
-40% -$2.34M
INCY icon
38
Incyte
INCY
$24.5B
$3.49M 1.3%
40,000
-15,000
-27% -$1.28M
ILMN icon
39
Illumina
ILMN
$29.1B
$3.32M 1.23%
+10,280
New +$3.12M
DGX icon
40
Quest Diagnostics
DGX
$26.2B
$2.94M 1.09%
27,500
-22,500
-45% -$2.35M
SRPT icon
41
Sarepta Therapeutics
SRPT
$1.92B
$2.9M 1.08%
22,500
+7,500
+50% +$757K
AVTR icon
42
Avantor
AVTR
$9.31B
$2.72M 1.01%
+150,000
New +$2.39M
ALC icon
43
Alcon
ALC
$36.7B
$2.55M 0.95%
45,000
-55,000
-55% -$3.15M
HRC
44
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$2.26M 0.84%
19,900
-10,100
-34% -$1.06M
SGEN
45
DELISTED
Seagen Inc. Common Stock
SGEN
$2.23M 0.83%
19,500
-500
-3% -$53K
BLUE
46
DELISTED
bluebird bio
BLUE
$1.75M 0.65%
+1,544
New +$1.68M
CRSP icon
47
CRISPR Therapeutics
CRSP
$5.23B
$1.52M 0.57%
+25,000
New +$1.36M
BPMC
48
DELISTED
Blueprint Medicines
BPMC
$1.48M 0.55%
18,520
-1,480
-7% -$111K
SAGE
49
DELISTED
Sage Therapeutics
SAGE
$1.08M 0.4%
15,000
+5,000
+50% +$615K
SPY icon
50
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$825K 0.31%
+5,000
New +$1.54M
1
2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q4 2019 Portfolio in Review

As of Q4 2019, Sivik Global Healthcare held 57 positions worth $269M, up 36% from $198M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Sivik Global Healthcare deployed $40.1M of net new capital in Q4 2019, opening 13 new positions and adding to 18 existing holdings. Its largest new stake was Bristol-Myers Squibb: 130,000 shares worth $8.35M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 96% a quarter earlier.

On the sell side, the largest reduction was Alcon, an estimated $3.15M trimmed.

  • Sivik Global Healthcare's largest Q4 2019 buy was Bristol-Myers Squibb: 130,000 shares worth $8.35M.
  • Sivik Global Healthcare added most to Centene in Q4 2019, an estimated $5.15M increase.
  • Sivik Global Healthcare's biggest Q4 2019 reduction was Alcon, cutting an estimated $3.15M.
  • Sivik Global Healthcare fully exited Wellcare Health Plans, Inc. in Q4 2019, selling an estimated $5.18M.
  • Sivik Global Healthcare's ten largest holdings make up 31% of its $269M portfolio in Q4 2019.
  • Sivik Global Healthcare opened 13 new positions and closed 7 in Q4 2019.
  • Sivik Global Healthcare's portfolio value rose 36% quarter-over-quarter to $269M.

Based on Sivik Global Healthcare's 13F filing for Q4 2019, filed 13 Feb 2020.